Back to Search
DR. CARLY RAE MOSKOWITZ MD
MD
Psychiatry Physician
NPI: 1962002584IndividualAccepts Medicare
Specialties, Licenses & Credentials
Psychiatry PhysicianPrimary
Psychiatry & Neurology — Psychiatry
Code: 2084P0800X
25MA12923700(NJ)332561(NY)
Education
ALBERT EINSTEIN COLLEGE OF MEDICINE OF YESHIVA UNIVERSITY
Class of 2020
Research & Publications (20)
A simulation study to evaluate the impact of the number of lesions measured on response assessment.
PMID 19095439·Eur J Cancer·2009
8-other
Estimating the empirical Lorenz curve and Gini coefficient in the presence of error with nested data.
PMID 18172873·Stat Med·2008
8-other
Maintaining the dose intensity of ICE chemotherapy with a thrombopoietic agent, PEG-rHuMGDF, may confer a survival advantage in relapsed and refractory aggressive non-Hodgkin lymphoma.
PMID 17872903·Ann Oncol·2007
3-trial
Pretreatment prognostic factors and outcome in patients with relapsed or primary-refractory diffuse large B-cell lymphoma treated with second-line chemotherapy and autologous stem cell transplantation.
PMID 16702184·Ann Oncol·2006
6-review
Comparing the predictive values of diagnostic tests: sample size and analysis for paired study designs.
PMID 16895044·Clin Trials·2006
4-observational
Cell of origin, germinal center versus nongerminal center, determined by immunohistochemistry on tissue microarray, does not correlate with outcome in patients with relapsed and refractory DLBCL.
PMID 16091454·Blood·2005
3-trial
Quantifying and comparing the accuracy of binary biomarkers when predicting a failure time outcome.
PMID 15122736·Stat Med·2004
4-observational
Quantifying and comparing the predictive accuracy of continuous prognostic factors for binary outcomes.
PMID 14744831·Biostatistics·2004
4-observational
Effectiveness of high dose chemoradiotherapy and autologous stem cell transplantation for patients with biopsy-proven primary refractory Hodgkin's disease.
PMID 14871252·Br J Haematol·2004
8-other
An update on the management of relapsed and primary refractory Hodgkin's disease.
PMID 15124135·Semin Oncol·2004
6-review
Risk-adapted therapy for relapsed and refractory lymphoma using ICE chemotherapy.
PMID 12042983·Cancer Chemother Pharmacol·2002
8-other
A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model.
PMID 11157476·Blood·2001
3-trial
Palliative care for people with late-stage Huntington's disease.
PMID 11854103·Neurol Clin·2001
6-review
Barriers to mental health service use among hematopoietic SCT survivors.
PMID 19597417·Bone Marrow Transplant·2010
8-other
Patients with chemotherapy-refractory mantle cell lymphoma experience high response rates and identical progression-free survivals compared with patients with relapsed disease following treatment with single agent bortezomib: results of a multicentre Phase 2 clinical trial.
PMID 19220284·Br J Haematol·2009
3-trial
CD5 negative, Cyclin D1-positive diffuse large B-cell lymphoma (DLBCL) presenting as ruptured spleen.
PMID 18838919·Appl Immunohistochem Mol Morphol·2009
5-case
Clinical measurement of mobility and balance impairments in Huntington's disease: validity and responsiveness.
PMID 19111470·Gait Posture·2009
8-other
Breast cancer surveillance practices among women previously treated with chest radiation for a childhood cancer.
PMID 19176442·JAMA·2009
4-observational
The role of FDG-PET imaging and involved field radiotherapy in relapsed or refractory diffuse large B-cell lymphoma.
PMID 19139730·Bone Marrow Transplant·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 3 locations total
- Address
- 53 FRONTAGE RD FL 1
HAMPTON, NJ 08827 - Phone
- (833) 351-8255
Quick Facts
- NPI
- 1962002584
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 3
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile